<DOC>
	<DOC>NCT02497950</DOC>
	<brief_summary>Evaluate real-world experience of HeartMate 3 (HM3) in post-approval setting.</brief_summary>
	<brief_title>HeartMate 3 ELEVATEâ„¢</brief_title>
	<detailed_description>The purpose of this post-market registry is to collect data and evaluate the real-world experience of the HeartMate 3 Left Ventricular Assist System (HM3 LVAS) in a post-approval setting.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<criteria>Inclusion: 1. Patient consented to registry data collection 2. Patient has met the HeartMate 3 commercially approved labeling indication and is implanted with the HM3.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>HeartMate 3</keyword>
	<keyword>LVAS</keyword>
	<keyword>LVAD</keyword>
	<keyword>Heart-assist devices</keyword>
	<keyword>Thoratec Corporation</keyword>
</DOC>